ABVC - ABVC BioPharma GAAP EPS of -$0.11 beats by $0.09 revenue of $0.04M beats by $0.01M November, 15 2022 09:00 AM ABVC BioPharma Inc. ABVC BioPharma press release ( NASDAQ: ABVC ): Q3 GAAP EPS of -$0.11 beats by $0.09 . Revenue of $0.04M (-55.6% Y/Y) beats by $0.01M . For further details see: ABVC BioPharma GAAP EPS of -$0.11 beats by $0.09, revenue of $0.04M beats by $0.01M